Results 51 to 60 of about 4,368,636 (230)

Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus

open access: yesViruses, 2018
Zika virus (ZIKV), a mosquito-borne flavivirus, was an almost neglected pathogen until its introduction in the Americas in 2015, where it has been responsible for a threat to global health, causing a great social and sanitary alarm due to its increased ...
Juan-Carlos Saiz   +4 more
doaj   +1 more source

A Review and Meta-Analysis of Influenza Interactome Studies

open access: yesFrontiers in Microbiology, 2022
Annually, the influenza virus causes 500,000 deaths worldwide. Influenza-associated mortality and morbidity is especially high among the elderly, children, and patients with chronic diseases.
Sonja Courtney Jun Hui Chua   +12 more
doaj   +1 more source

Identification of a Shiga toxin A‐derived peptide internalized into Gb3 receptor‐bearing cells via interaction with the Shiga toxin B subunit

open access: yesFEBS Letters, EarlyView.
The process of internalization of the Shiga toxin A subunit via formation of a complex with the Shiga toxin B subunit, which specifically binds to the Gb3 receptor. The peptide is designed to act as a carrier of drugs into cancer cells. Here, we explored the potential of peptides derived from the catalytic A subunit of Shiga toxin (STxA) to be drug ...
Giulia Opassi   +6 more
wiley   +1 more source

Development of Broad-Spectrum Antiviral Agents—Inspiration from Immunomodulatory Natural Products

open access: yesViruses, 2021
Developing broad-spectrum antiviral drugs remains an important issue as viral infections continue to threaten public health. Host-directed therapy is a method that focuses on potential targets in host cells or the body, instead of viral proteins.
Mengxun Zhang   +5 more
doaj   +1 more source

Occupational therapy assessment of open-road driving performance: validity of directed and self-directed navigational instructional components

open access: yes, 2004
OBJECTIVE: The purpose of this study was to validate an assessment tool used by occupational therapists to evaluate on-road driving performance. METHODS: The driving assessment was conducted over a 15-km route that consisted of a range of traffic ...
Wood, Joanne M.   +3 more
core   +1 more source

Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential

open access: yesFEBS Letters, EarlyView.
Aging reshapes the gut microbiome (↓SCFA‐producing commensals; ↑pro‐inflammatory outputs), shifting circulating metabolites (↓SCFAs; ↑LPS, ↑TMAO, ↑PAA) that act at the BBB to increase nonspecific transcytosis, alter transport, and promote astrocyte reactivity, heightening brain vulnerability.
Daniel Cuervo‐Zanatta   +3 more
wiley   +1 more source

An epithelial GPR35 isoform supports tumor‐associated transcriptional and metabolic phenotypes

open access: yesFEBS Letters, EarlyView.
GPR35 generates two functionally distinct isoforms with previously unresolved roles. GPR35‐short mediates immune‐cell chemotaxis, while GPR35‐long is enriched in colorectal cancer epithelium, where it supports increased metabolism, proliferation, and tumor‐associated transcriptional programs.
Jørgen D. Rønneberg   +14 more
wiley   +1 more source

Anti-PD-1/PD-L1 therapy for infectious diseases: learning from the cancer paradigm

open access: yesInternational Journal of Infectious Diseases, 2017
Objectives: Immune checkpoint pathways regulate optimal host immune responses against transformed cells, induce immunological memory, and limit tissue pathology.
Martin Rao   +4 more
doaj   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

Recent and New Strategies for Extensively Drug-resistant Tuberculosis

open access: yesMediterranean Journal of Infection, Microbes and Antimicrobials, 2018
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant TB (XDR-TB) are very problematic clinical conditions due to the few therapeutic options and long course of treatment.
Güneş Şenol
doaj   +1 more source

Home - About - Disclaimer - Privacy